Consolidated Balance Sheets - USD ($) $ in Millions	Jun. 30, 2017	Jun. 30, 2016
Current assets:
Cash and cash equivalents	$ 102.4	$ 68.5
Marketable investment securities	48.3	90.5
Prepaid expenses	12.7	18.4
Inventory	42.2	38.3
Trade accounts receivable, less allowance for doubtful accounts of $8.2 in 2017 and $6.8 in 2016	105.6	91.7
Prepaid taxes	0.2	3.8
Other receivables	5.7	3.3
Total current assets	317.1	314.5
Property, plant and equipment, net	51.1	58.3
Long-term marketable investment securities	48.5	79.9
Intangibles, net	491.6	227.5
Goodwill	316.1	195.3
Other assets		5.0
Total assets	1,224.4	880.5
Current liabilities:
Accounts payable	22.0	21.1
Accrued liabilities	65.6	49.5
Short-term contingent consideration	127.3
Deferred revenue	2.6	1.7
Total current liabilities	217.5	72.3
Unrecognized tax benefits	25.2	24.0
Other long-term liabilities	7.2	7.8
Contingent consideration	13.2	10.4
Long-term debt	99.1
Long-term deferred taxes	84.4	17.9
Total liabilities	446.6	132.4
Commitments and contingencies
Stockholders’ equity:
Common stock, 68.4 and 69.1 shares outstanding at June 30, 2017 and 2016 respectively	0.7	0.7
Additional paid-in capital	851.4	830.1
Accumulated other comprehensive loss	(5.5)	(9.5)
Accumulated deficit	(68.4)	(73.2)
Total Myriad Genetics, Inc. stockholders' equity	778.2	748.1
Non-controlling interest	(0.4)
Total stockholders' equity	777.8	748.1
Total liabilities and stockholders’ equity	$ 1,224.4	$ 880.5

Prepaid expense excluding prepaid taxes current.

No definition available.

Name:	mygn_PrepaidExpenseExcludingPrepaidTaxesCurrent
Namespace Prefix:	mygn_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).